2016/Chen/China [24]
|
Case series
|
55/64
|
34.1 (22–45)
|
53/5a
|
ARCO:
I (21)/II (35)/III (8)
|
Alcohol abuse (58)a
|
2.87 (2–4)/5.17%
|
M
|
2014/Elmali/Turkey [25]
|
Case series/retrospective
|
22/26
|
36 (16–48)
|
14/8
|
ARCO:
II (11)/III (15)
|
Steroid use (13 patients)/alcohol abuse (2)/idiopathic (5)/pregnancy (2)
|
3 (1.17–5.17)/NA
|
H
|
2009/Chen/China [26]
|
Case series/retrospective
|
32/33
|
37 (23–64)
|
31/1
|
ARCO:
IIIA (26), IIIB (7)
|
Steroid use (1 patients)/alcohol abuse (26)/idiopathic (5)
|
5.75 (0.67–13.75)/13.15%
|
M
|
2009/Babhulkar/India [27]
|
Case series/retrospective
|
31/31
|
32 (18–52)
|
26/5
|
ARCO:
IIB (9)/IIIC (22)
|
Steroid use (12 patients)/alcohol abuse (16)/idiopathic (3)
|
8/NA
|
M
|
2009/Baksi/India [28]
|
Case series
|
141/176
|
35.5 (16–62)
|
91/61a
|
Ficat and Arlet:
I (4)/II (75)/III (97)
|
Steroid use (56 hips)/alcohol abuse (7)/trauma (40)/idiopathic (83)/gout (1)a
|
16.5 (10–21.5)/
7.23%
|
M
|
2006/Zhao/China [29]
|
Case series/retrospective
|
197/226
|
38 (19–65)
|
126/71
|
Ficat and Arlet:
II (91)/III (93)/IV (42)
|
Steroid use (53 patients)/alcohol abuse (14)/trauma (58)/idiopathic (51)/hyperlipidemia (9)/infection (11)/pregnancy (1)
|
12.5 (6–19)/6.63%
|
M
|
2004/Nagoya/Japan [30]
|
Case series
|
29/35
|
35 (17–62)
|
20/9
|
ARCO:
II (28)/III (7)
JIC classification:
C1 (17), C2 (18)
|
Steroid use (14 patients)/alcohol abuse (10)/idiopathic (5)
|
8.58 (3–17)/NA
|
H
|
2001/Eisenschenk/Germany [31]
|
Case series
|
82/82
|
NA
|
81/21 a
|
ARCO:
I-II (62)/III (1)/IV (19)
|
Steroid use (12 patients)/alcohol abuse (20)/trauma (22)/diabetes (6)/hyperlipidemia (10)/sickle cell disease (1)/unknown (11)
|
5 (0.5–10)/19.61%b
|
VH
|
1997/Hasegawa/Japan [33]
|
Case series
|
26/31
|
38.3 (25–53)
|
23/3
|
Inoue and Ono classification:
II (28)/IIIA (3)
JIC classification:
IB (25)/IC (4)/II (4)/
IIIB (1)
|
Steroid use (6 patients)/alcohol abuse (15)/idiopathic (5)
|
8 (5–11)/100%
|
M
|
1997/Ishizaka/Japan [32]
|
Case series
|
24/31
|
33 (15–66)
|
16/81
|
Ficat and Arlet:
II (18)/III (13)
|
Steroid use (17 hips)/alcohol abuse (10)/idiopathic (4)
|
6 (2–11)/22.58% patient
|
H
|
1996/Leung/China [35]
|
Case series
|
18/21
|
32 (24–52)
|
12/6
|
Myer’s classification:
III (6)/IV (8)/V (7)
|
Steroid use (7 hips)/alcohol abuse (3)/trauma (3)/idiopathic (8)
|
NA (2–11)/NA
|
H
|
1996/Wassenaar/Netherlands [34]
|
Case series
|
9/12
|
37.5 (14–54)
|
5/4
|
Ficat and Arlet:
II (5)/III (7)
|
Steroid use (3 patients)/alcohol abuse (1)/trauma (3)/chemotherapy (1)/sickle cell disease (1)
|
4.17/30.77%
|
VH
|
1993/Iwata/Japan [36]
|
Case series
|
19/23
|
39 (25–53)
|
17/2
|
JIC stage:
II (20), III (3)
JIC classification:
I-C (19)/II (2)/III-B (1)
|
Steroid use (3 patients)/alcohol abuse (13)/idiopathic (3)
|
2.91 (1–6)/100%
|
H
|